Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters
We investigate the long-term impact of repeated COVID-19 vaccinations on adaptive immunity through a 3-year study of 78 individuals without reported symptomatic infections. We observe distinct dynamics in spike-specific responses across multiple vaccine doses. While antibody levels increase and stab...
Saved in:
Published in | Cell reports (Cambridge) Vol. 44; no. 7; p. 115907 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
22.07.2025
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 2211-1247 2211-1247 |
DOI | 10.1016/j.celrep.2025.115907 |
Cover
Summary: | We investigate the long-term impact of repeated COVID-19 vaccinations on adaptive immunity through a 3-year study of 78 individuals without reported symptomatic infections. We observe distinct dynamics in spike-specific responses across multiple vaccine doses. While antibody levels increase and stabilize with each booster, T cell responses quickly plateau and remain stable. Notably, approximately 30% of participants show evidence suggestive of asymptomatic infections. Single-cell RNA sequencing reveals a diverse and stable landscape of spike-specific T cell phenotypes without signs of exhaustion or functional impairment. Individuals with evidence of asymptomatic infection display increased frequencies of Th17-like CD4+ T cells and GZMKhi/IFNR+ CD8+ T cell subsets. In this group, repeated vaccinations correlate with an increase in regulatory T cells, potentially indicating a balanced immune response that may mitigate immunopathology. By regularly stimulating T cell memory, boosters contribute to a stable and enhanced immune response, which may provide better protection against symptomatic infections.
[Display omitted]
•≈30% of participants show evidence of asymptomatic infections despite no symptoms•Antibody levels increase with each booster; T cell responses plateau early and stabilize•Single-cell analysis reveals stable T cell phenotypes without exhaustion after boosters•Asymptomatic cases develop more regulatory T cells, potentially preventing pathology
da Silva Antunes et al. examine SARS-CoV-2-specific immunity across 3 years of repeated vaccinations. While antibodies increase with each booster, T cells responses plateau early and remain stable without signs of exhaustion or functional impairment. Asymptomatic infections promote Th17-like and regulatory CD4+ T cell expansion, suggesting balanced immunity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2211-1247 2211-1247 |
DOI: | 10.1016/j.celrep.2025.115907 |